The results of animal and cell models of NAFLD revealed that the expression of CPT1α and Lcad descended markedly after VEGFB gene was suppressed (Fig. 8G, H). The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatotic liver disease.